Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Condensed Consolidated Statements Of Operations        
Product revenue $ 2,902,155 $ 1,821,229 $ 7,226,368 $ 4,596,490
License and other revenue 35,708 31,184 107,125 68,962
Total Revenues 2,937,863 1,852,413 7,333,493 4,665,452
OPERATING EXPENSES        
Cost of product revenue 1,735,771 1,112,782 4,346,433 2,808,726
Research and development 1,677,263 2,111,505 7,104,864 5,019,138
Plasma centers 1,482,586 1,214,158 4,057,306 3,359,130
General and administrative 1,779,115 2,078,166 5,211,148 4,861,598
TOTAL OPERATING EXPENSES 6,674,735 6,516,611 20,719,751 16,048,592
LOSS FROM OPERATIONS (3,736,872) (4,664,198) (13,386,258) (11,383,140)
OTHER INCOME (EXPENSE):        
Interest income 11,605 11,102 37,130 25,878
Interest expense (605,972) (449,328) (1,611,411) (1,378,778)
Other income 0 0 4,496 0
Change in fair value of stock warrants 0 0 0 67,860
Loss on extinguishment of debt 0 0 0 (719,097)
OTHER EXPENSE, NET (594,367) (438,226) (1,569,785) (2,004,137)
NET LOSS $ (4,331,239) $ (5,102,424) $ (14,956,043) $ (13,387,277)
NET LOSS PER COMMON SHARE - Basic and Diluted $ (0.34) $ (0.48) $ (1.26) $ (1.28)
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted 12,886,741 10,707,728 11,906,276 10,425,310